共 50 条
Practice guidelines Non-invasive diagnosis and follow-up of primary biliary cholangitis
被引:4
|作者:
Corpechot, Christophe
[1
,2
]
Heurgue, Alexandra
[3
]
Tanne, Florence
[6
]
Potier, Pascal
[7
]
Hanslik, Bertrand
[8
]
Decraecker, Marie
[4
,5
]
de Ledinghen, Victor
[4
,5
]
Ganne-Carrie, Nathalie
[9
,10
]
Bureau, Christophe
[11
]
Bourliere, Marc
[12
,13
]
机构:
[1] Hop St Antoine, AP HP, Serv Hepatogastroenterol, 184 Rue Faubourg St Antoine, F-75012 Paris, France
[2] Univ Paris Sorbonne, Reference Ctr Inflammatory Biliary Dis & Autoimmu, French Network Rare Liver Dis Children & Adults F, European Reference Network Rare Hepatol Dis ERN R, Paris, France
[3] CHU Reims, Serv Hepatogastroenterol & Cancerol Digest, Reims, France
[4] CHU Bordeaux, Hop Haut Leveque, Serv Hepatogastroenterol, Pessac, France
[5] Univ Bordeaux, INSERM U1053, Bordeaux, France
[6] CHRU Brest Cavale Blanche, Serv Hepatogastroenterol, Brest, France
[7] CHR Orleans, Serv Hepatogastroenterol & Oncol Digest, Orleans, France
[8] Ctr Montpellierain Malad Foie & Appareil Digestif, Montpellier, France
[9] Univ Sorbonne Paris Nord, Hop Avicenne, AP HP, Serv Hepatol, Bobigny, France
[10] Univ Paris, Ctr Rech Cordeliers, INSERM UMR 1138, Paris, France
[11] CHU Toulouse, Serv Hepatol, Hop Rangueil, Toulouse, France
[12] Aix Marseille Univ, Serv Hepatogastroenterol, Hop St Joseph, Marseille, France
[13] Aix Marseille Univ, INSERM UMR 1252 IRD SESSTIM, Marseille, France
关键词:
PBC;
ACID-TREATED PATIENTS;
URSODEOXYCHOLIC ACID;
BIOCHEMICAL RESPONSE;
GRADING SYSTEM;
CIRRHOSIS;
PROGNOSIS;
PROGRESSION;
RISK;
PREDICTION;
SURVIVAL;
D O I:
10.1016/j.clinre.2021.101770
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Primary biliary cholangitis (PBC) is a chronic inflammatory disease of the intra-hepatic bile ducts [1] . It is characterised biologically by chronic cholestasis associated with the presence of specific autoantibodies, and histologically by lesions of nonsuppurative destructive cholangitis. If left untreated it can progress to cirrhosis, portal hypertension and liver failure. Diagnosis, staging and follow-up are largely based on non-or minimally-invasive assessment (blood tests, ultrasound, liver stiffness measurement). Histological examination of the liver and upper gastrointestinal endoscopy are sometimes necessary, but their indications remain limited. The purpose of this chapter is to provide the clinicians with what should be known about the non-invasive assessment of PBC and to provide specific recommendations for clinical practice. (c) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:8
相关论文